Physician profile
Robert Henry Becker
NPI 1902193311
$556.26
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $93.16 · 2021: $44.88 · 2022: $15.00 · 2023: $14.99 · 2024: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $215.10 | 2019-2024 | Ozempic, Rybelsus |
| Abbott Laboratories | $74.64 | 2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $62.94 | 2019-2024 | |
| Lilly USA, LLC | $56.41 | 2020-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.67 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $27.56 | 2019 | |
| Insulet Corporation | $23.62 | 2020 | |
| Horizon Therapeutics Plc | $17.42 | 2021 | |
| Amgen INC. | $12.36 | 2019 | |
| Medtronic Minimed, INC. | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.